| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/08/2004 | WO2004014361A9 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
| 04/08/2004 | WO2004014360A3 Pharmaceutical compositions for the treatment of urinary incontinence |
| 04/08/2004 | WO2004013153A3 Macrolide compounds endowed with antiinflammatory activity |
| 04/08/2004 | WO2004012722A3 Bicifadine formulation |
| 04/08/2004 | WO2004012721A3 Hot melt tts for administering rotigotine |
| 04/08/2004 | WO2004011444A3 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 04/08/2004 | WO2004010984A3 Microcapsules with modified release of active principles with low solubility for oral delivery |
| 04/08/2004 | WO2004009565A3 Acylaminothiazole derivatives, preparation and therapeutic use thereof |
| 04/08/2004 | WO2004009124A3 Ghrelin-carrier conjugates |
| 04/08/2004 | WO2004009072A3 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 04/08/2004 | WO2004009061A3 Bioavailability/bioefficacy enhaning activity of cuminum cyminum and extracts and fractions thereof |
| 04/08/2004 | WO2004007764A3 Chromosome 3, 5 and 11 genes involved in premature canities |
| 04/08/2004 | WO2004007676A3 Combination therapy for the treatment of neoplasms |
| 04/08/2004 | WO2004007522A3 Hormone-based nitrogen monoxide donor compounds and use thereof in obstetrics and gynecology |
| 04/08/2004 | WO2004007512A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 04/08/2004 | WO2004007441A3 Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same |
| 04/08/2004 | WO2004006937A3 Novel pharmaceutical compositions based on 5-alpha-reductase inhibitors and uses of same |
| 04/08/2004 | WO2004006911A3 Compositions intended for the treatment of peripheral neuropathies, preparation thereof and uses of same |
| 04/08/2004 | WO2004006833A3 Bowel cleansing composition |
| 04/08/2004 | WO2004004634A3 Infertility treatment with exemestane |
| 04/08/2004 | WO2004004599A3 Epa and dha enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
| 04/08/2004 | WO2004002486A3 Ciprofloxacin hci |
| 04/08/2004 | WO2004000227A3 Use of thio-oxindole derivatives in treatment of skin disorders |
| 04/08/2004 | WO2004000224A3 Enhancing treatment of mdr cancer with adenosine a3 antagonists |
| 04/08/2004 | WO2004000223A3 Rapidly disintegrating formulations for treating or preventing mucositis |
| 04/08/2004 | WO2004000205A3 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 04/08/2004 | WO2003106452A3 Antagonists of melanin concentrating hormone receptor |
| 04/08/2004 | WO2003106431A3 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 04/08/2004 | WO2003105822A8 Long chain unsaturated oxygenated compounds and their use in the therapeutical, cosmetic and nutraceutical field |
| 04/08/2004 | WO2003105775A3 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 04/08/2004 | WO2003105769A3 Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases |
| 04/08/2004 | WO2003105611A3 Beverages containing plant sterols |
| 04/08/2004 | WO2003104473A8 Galactosyl isomalt, method for production and use thereof |
| 04/08/2004 | WO2003103709A3 Cd200-receptor mediated modulation of bone development |
| 04/08/2004 | WO2003103580A3 Combinations for the treatment of rheumatoid arthritis |
| 04/08/2004 | WO2003101392A3 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods |
| 04/08/2004 | WO2003101384A3 Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone |
| 04/08/2004 | WO2003100023A3 Manipulation of the rate of gastrointestinal transit by modulating intestinal methane concentration |
| 04/08/2004 | WO2003099218A3 Anti-cancer formulation |
| 04/08/2004 | WO2003097622A3 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof |
| 04/08/2004 | WO2003097055A3 Inhibitors of resistance to bacteria antibiotics |
| 04/08/2004 | WO2003092701A3 Substituted aminoalkanephosphonic acids for the treatment of neuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other ocular disorders |
| 04/08/2004 | WO2003092633A3 Diffusion-controlled dosage form and method of fabrication including three dimensional printing |
| 04/08/2004 | WO2003092578A3 Further syntheses of cyproterone acetate |
| 04/08/2004 | WO2003087121A8 Branched polyamine steroid derivatives |
| 04/08/2004 | WO2003087021A3 Nanoparticle delivery systems and methods of use thereof |
| 04/08/2004 | WO2003086314A3 Tyrosine kinase inhibitors |
| 04/08/2004 | WO2003084521A3 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 04/08/2004 | WO2003084503A3 P38 kinase inhibitors for treating mucus hypersecretion_ |
| 04/08/2004 | WO2003083135A3 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) |
| 04/08/2004 | WO2003082832A3 Anxiolytic agents with reduced sedative and ataxic effects |
| 04/08/2004 | WO2003080024A3 Nanoparticulate compositions of map kinase inhibitors |
| 04/08/2004 | WO2003077860A3 BOSWELLIN COMPOSITIONS ENHANCED WITH 3-β-ACETYL-11-KETO-β-BOSWELLIC ACID (“AKBA”), INDUSTRIAL MANUFACTURE AND THEIR USES |
| 04/08/2004 | WO2003076602A3 Use of l-$g(a)-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo |
| 04/08/2004 | WO2003074060A3 Dna demethylase antisense and chemotherapy combination |
| 04/08/2004 | WO2003070690A3 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 04/08/2004 | WO2003070175A3 Use of opioid compound to treat a neurologic or neurogenic disorder |
| 04/08/2004 | WO2003068732A3 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds |
| 04/08/2004 | WO2003068140A3 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
| 04/08/2004 | WO2003066077A3 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 04/08/2004 | WO2003057225A3 Phosphate transport inhibitors |
| 04/08/2004 | WO2003051276B1 Therapeutic heterocycles |
| 04/08/2004 | WO2003027068A3 Substituted amines for the treatment of neurological disorders |
| 04/08/2004 | WO2003024223A8 Pesticidal formulations |
| 04/08/2004 | WO2003022209A9 Crystalline forms of valacyclovir hydrochloride |
| 04/08/2004 | WO2003018553A8 Oral antidiabetic agents |
| 04/08/2004 | WO2003018013B1 Stilbene derivative having cytochrome p450 1b1 inhibitory activity, pharmaceutically acceptable salt thereof, method for preparing the same, and composition including the same |
| 04/08/2004 | WO2003014300A3 TRPS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 04/08/2004 | WO2003009881A3 Novel targeted delivery system for bioactive agents |
| 04/08/2004 | WO2003003806A3 Dye-azide compounds for dual phototherapy |
| 04/08/2004 | WO2003001968A8 Compositions and methods for inhibiting platelet activation and thrombosis |
| 04/08/2004 | WO2002100373B1 Skin preparation |
| 04/08/2004 | WO2002099074A8 Slc7s as modifiers of the p53 pathway and methods of use |
| 04/08/2004 | WO2002092008A3 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 04/08/2004 | WO2002085268A9 Disposal system for transdermal dosage form |
| 04/08/2004 | WO2002081668A9 Desaturase genes and uses thereof |
| 04/08/2004 | WO2002071866A9 Method and product for treating cancer in pets |
| 04/08/2004 | WO2001087839A8 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 04/08/2004 | US20040068268 Devices and methods for the restoration of a spinal disc |
| 04/08/2004 | US20040068207 Active oxygen generator containing photosensitizer for ultrasonic therapy |
| 04/08/2004 | US20040068129 Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength |
| 04/08/2004 | US20040068123 Introduction of t-butyldimethylsilyl(TBDMS) group as an alcohol protection group and construction of deprotection reaction condition not to produce by-products promise highly pure production of simvastatin |
| 04/08/2004 | US20040068122 Delta1-pyrrolines used as pesticides |
| 04/08/2004 | US20040068121 A key intermediate in the synthesis of atorvastatin calcium |
| 04/08/2004 | US20040068120 Arylated furan- and thiophenecarboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
| 04/08/2004 | US20040068118 Conjugated aromatic compounds with a pyridine substituent |
| 04/08/2004 | US20040068109 Activated blood coagulation factor X inhibitor and also to such a pharmaceutical agent and particularly has an excellent activity by oral administration |
| 04/08/2004 | US20040068108 Disaccharide sequences formed by uronic acid and hexose as to form polysaccharides of 8-24 monosaccharide units whose hydroxyl groups are substituted by alkyl or sulphate groups; possible to modulate activities of glycosaminoglycans type |
| 04/08/2004 | US20040068105 Plant thermogenic genes and proteins |
| 04/08/2004 | US20040068039 PVA embolic materials are prepared through saponifying poly(vinyl pivalate) |
| 04/08/2004 | US20040068020 Patient oxygenation using stabilized fluorocarbon emulsions |
| 04/08/2004 | US20040068018 Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate |
| 04/08/2004 | US20040068017 Small organic molecules that increase the activity of Gelatinase A in ocular cells |
| 04/08/2004 | US20040068016 C2-substituted idan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals |
| 04/08/2004 | US20040068015 Prevention constriction of vascular system; metalloproteinase inhibitor |
| 04/08/2004 | US20040068014 Medicinal compositions comprising diclofenac and ornoprostil |
| 04/08/2004 | US20040068013 Supplying in situ using amino acid; immobilization |
| 04/08/2004 | US20040068010 Moderating behavior |
| 04/08/2004 | US20040068009 Systemic formulations containing beta-carotene and derivatives thereof |
| 04/08/2004 | US20040068007 Diclofenac salt of lidocaine |